Foundation Medicine
22 cited products
143 protocol citations
Foundation Medicine is a leading provider of comprehensive genomic profiling solutions for cancer research and clinical applications.
The company's portfolio includes a range of research products, including next-generation sequencing (NGS) assays, bioinformatics software, and analytical services.
Foundation Medicine's research products are widely used across various research protocols, as evidenced by their extensive citation and usage data in scientific publications, preprints, and patents.
Researchers can explore this data on PubCompare.ai to understand how Foundation Medicine's products have been leveraged to support diverse scientific work.
The company's offerings span equipment, consumables, reagents, and software, catering to the needs of the oncology research community.
By offering comprehensive genomic profiling capabilities, Foundation Medicine enables researchers to gain deeper insights into the molecular drivers of cancer, accelerating advancements in cancer research and the development of targeted therapies.
The company's portfolio includes a range of research products, including next-generation sequencing (NGS) assays, bioinformatics software, and analytical services.
Foundation Medicine's research products are widely used across various research protocols, as evidenced by their extensive citation and usage data in scientific publications, preprints, and patents.
Researchers can explore this data on PubCompare.ai to understand how Foundation Medicine's products have been leveraged to support diverse scientific work.
The company's offerings span equipment, consumables, reagents, and software, catering to the needs of the oncology research community.
By offering comprehensive genomic profiling capabilities, Foundation Medicine enables researchers to gain deeper insights into the molecular drivers of cancer, accelerating advancements in cancer research and the development of targeted therapies.
22 products from Foundation Medicine
Sourced in United States
FoundationOne CDx is a comprehensive genomic profiling test that analyzes the DNA of a patient's cancer sample to identify genomic alterations that may be driving the growth and development of the cancer. The test is designed to detect substitutions, insertion and deletion alterations, and copy number alterations in 324 genes, as well as select gene rearrangements. The results of the test can help inform treatment decisions for patients with solid tumors.
Sourced in United States
FoundationOne is a comprehensive genomic profiling assay designed to identify the genomic alterations in a patient's tumor. The assay analyzes hundreds of cancer-related genes to provide insights into the molecular makeup of a patient's cancer.
Sourced in United States
FoundationOne CDx is a comprehensive genomic profiling assay that analyzes the tumor's DNA to identify genomic alterations. The assay evaluates multiple genes associated with solid tumors to provide information that can guide treatment decisions.
Sourced in United States
FoundationOne Heme is a comprehensive genomic profiling assay designed to analyze the genomic alterations in a patient's solid tumor or hematologic malignancy sample. The assay utilizes next-generation sequencing technology to detect mutations, insertions, deletions, copy number alterations, and rearrangements across hundreds of cancer-related genes.
Sourced in United States
FoundationOne Liquid CDx is a laboratory equipment product developed by Foundation Medicine. It is a comprehensive liquid biopsy test that analyzes circulating tumor DNA (ctDNA) to detect genomic alterations across hundreds of cancer-related genes. The test is designed to provide genomic information to support cancer diagnosis, treatment selection, and monitoring.
Sourced in United States
Next-generation sequencing is a technology that enables the rapid and efficient sequencing of DNA or RNA molecules. It provides a high-throughput approach to analyzing the genetic composition of a sample, allowing for the simultaneous detection of multiple genetic alterations or sequences.
The FoundationOne platform is a comprehensive genomic profiling assay that analyzes the key genes known to drive cancer growth and development. It is designed to detect genomic alterations in solid tumors and provide clinicians with actionable insights to guide patient treatment decisions.
Sourced in United States
FoundationOne is a comprehensive genomic profiling test that analyzes the DNA of a patient's cancer cells to identify genomic alterations. The test is designed to provide information about the molecular makeup of a patient's tumor, which can be used to guide treatment decisions.
Sourced in United States
FoundationOne® is a comprehensive genomic profiling (CGP) assay that analyzes the DNA of a patient's tumor sample to identify genomic alterations. This assay is designed to detect substitutions, insertion and deletion alterations, and copy number alterations in hundreds of cancer-related genes, as well as genomic signatures including microsatellite instability and tumor mutational burden.
Sourced in United States
Foundation One® CDx (F1CDx) is a comprehensive genomic profiling (CGP) assay that analyzes DNA and RNA from a patient's tumor sample to identify genomic alterations. The assay is designed to detect substitutions, insertion and deletion alterations, and copy number alterations in 324 genes, as well as select gene rearrangements. The results from the F1CDx assay can inform treatment decisions for patients with solid tumors.
Company FAQ
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!